Upcoming Events
Sebastian A. Brunemeier, Partner & Co-Founder of Healthspan Capital
Title: "The Longevity Biotech (LongBio) Revolution: Building Companies and Investing in Geroscience"
This talk will cover the cutting edge science of longevity therapeutics, the companies and investors in the field, and how targeting aging will be a revolution in medicine.
See this report from Healthspan Capital on the leading companies in the LongBio field: https://www.healthspancapital.vc/longbio-report-2025
Past events:
Dr. Peshkin, Harvard Medical School
Abstract: In this presentation, Dr. Leonid Peshkin will critically examine the pervasive challenges in contemporary longevity research, with a focus on the absence of universally accepted standards for conducting and reporting experimental studies. The inconsistencies in lifespan data across different research endeavors frequently result in ambiguous conclusions regarding the efficacy of various aging interventions.
Dr. Furman, Buck Institute & Stanford University
Talk Title: The Time Machine: Where Physics and Biology Converge to Change the Course of Aging
Abstract: Research from NASA and the European Space Agency have demonstrated accelerated biological aging as a result of spaceflight. These effects on the human body are largely attributed to microgravity. Cosmica uses simulated microgravity in their ‘Older Twin’ technology, which enables the accurate prediction of future aging biology in an individual with applications in precision longevity medicine.
Dr. Headley, Stanford University
Abstract: Harnessing mitochondrial transplantation to increase health-span: Similar to replacing an old engine in a car, my research is geared toward understanding and optimizing Mitochondrial transplantation for sustained cellular health during aging.
Dr. Boominathan, SENS Research Foundation
Talk Title: Rejuvenating the Aging Mitochondria: Perspectives and Strategies
Abstract: Mitochondrial dysfunction is a key feature of many age-related diseases, and the role of mitochondrial DNA in these conditions is a rapidly evolving area of research. Dr. Boominathan will discuss the involvement of mitochondrial DNA in both inherited and age-related diseases, highlighting the strategies her lab is developing to identify potential therapeutics aimed at mitigating these disorders
Tom Benson, Mitrix Bio
Abstract: In a groundbreaking talk, the CEO of Mitrix Bio will discuss their planned 2025 human trials which will attempt the first "130-Year Lifespan" for 15 human volunteers. He will introduce Mitrix Bio's pioneering technology of using young bioreactor-grown mitochondria, termed "Mitlets," encapsulated in vesicles to rejuvenate cellular function. He will underscore their mission to prototype essential components and techniques, aiming for a fundamental advancement in human medicine worldwide.
Stephanie Dainow, Lifespan Research Institute (LRI)
Abstract: Join Stephanie Dainow, co-founder and Chief Business Officer of the Lifespan Research Institute (LRI), for a deep dive into the fundamentals of longevity, how you can contribute to its acceleration, and why mainstream adoption is critical. This talk explores the history of longevity advocacy, key misconceptions slowing progress, and the role of incentive structures in shaping investment, policy, and research. Learn about LRI’s mission to develop, represent, and promote the longevity biotech industry, bridging the gap between science, startups, and funding.
Robin Mansukhani, Deciduous Therapeutics
Abstract: Get ready to dive into the future of health and longevity as Robin Mansukhani shares groundbreaking insights from Deciduous Therapeutics. Discover how Deciduous is restoring immune function to enable the removal of pathological senescent cells, a significant driver of several age related diseases.
Tal Galfsky, Altos Labs
Abstract: Dive into the world of biohacking with an exclusive workshop led by Tal Galfsky, a staff machine learning engineer at Altos Labs. Whether you're a seasoned biohacker or just curious, this is your chance to learn cutting-edge techniques to enhance your longevity while enjoying great company and delicious food.
Joel Shor, ex-Google, ex-Verily, ex-Deep Genomics
Abstract: RNA therapeutics have revolutionized medicine, from COVID vaccines to rare disease treatments. But rational design of RNA sequences, for instance that can effectively deliver drugs to specific cells, remains a grand challenge in biotechnology - one that represents both a massive market opportunity and an important scientific puzzle.
In this talk, we'll discuss how predictive models of DNA and RNA biology are being used to design biomolecules, and the impact it might have on drug discovery.